We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Gemini Bio Announces Dedicated Support for COVID-19 Research

Gemini Bio Announces Dedicated Support for COVID-19 Research content piece image
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Gemini Bioproducts, LLC (Gemini Bio), a supplier of cell culture solutions, has announced its effort to help support COVID-19 research.

To support labs pivoting to COVID-19 research, Gemini Bio is prioritizing products and services to assist its customers in four key areas: cell culture, viral harvesting and transport, research tools, and analytical instruments.

Moxi Go II, an analytical instrument

Gemini carries gold-standard cell and protein analysis instrumentation through its line of Moxi products. The Moxi Go has the potential to enable simultaneous, rapid analysis of antibodies and cytokines tied to COVID-19. The Moxi Go uniquely combines highly accurate and precise cell counting and volumetric sizing with the cell and protein analysis capabilities of a flow cytometer.

The Moxi Go instrument is differentiated by its accuracy, its small footprint for easy deployment, its speed – with tests running in less than 20 seconds – and its ability to calibrate every test independently. The instrument has a touchscreen for easy, intuitive use so that technicians will be able to easily navigate the system menus. Moreover, the instrument is fully self-contained, requiring no cleaning fluids or maintenance, making it ideal for cell culture suites, BSL2/3/4 settings with limited space.